Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM

Summary

Conduct a community intervention study that will 1) validate a screening approach to identify patients at risk for advanced NAFLD in the obese or T2DM population, and 2) test whether semaglutide treatment is effective for the management of significant fibrosis due to NAFLD in high-risk patients.

Timeline

Start

2023-07-25

Primary completion

2026-12-31

Completion

2026-12-31

Drugs

Indications